Characteristics and Survival of Intensive Care Unit Patients with Coronavirus Disease in Osaka, Japan: A

Ling Zha1, Tomotaka Sobue1, Taro Takeuchi1

  • 1Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita 565-0871, Japan.

Insights

This study analyzed 205 intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) in Japan. Older age, particularly over 80, significantly increased mortality risk in ICU patients with COVID-19.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Limited data exists on the intensive care unit (ICU) management and outcomes for coronavirus disease 2019 (COVID-19) patients in Japan.
  • Understanding the characteristics of severe COVID-19 cases is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To evaluate the epidemiological and clinical features, treatments, and outcomes of COVID-19 patients admitted to ICUs in Osaka Prefecture, Japan.
  • To identify factors associated with mortality in this patient cohort.

Main Methods:

  • Analysis of registry data from 205 COVID-19 ICU patients admitted between February and November 2020.
  • Utilized a Cox proportional hazards model to assess mortality risk factors.
  • Follow-up data on patient outcomes at discharge.

Main Results:

  • The majority of ICU patients were male (78.5%) and over 60 years old (72.7%).
  • Comorbidities were present in 57.1% of patients; 91.2% required mechanical ventilation, and 15.6% needed extracorporeal membrane oxygenation.
  • Mortality rate was 28.3%; patients over 80 years old had a significantly higher hazard ratio for mortality (6.02) compared to those ≤59 years old.

Conclusions:

  • The study highlights the significant impact of age, particularly advanced age, on mortality risk in severe COVID-19 patients requiring ICU care.
  • Findings provide valuable insights into the clinical course and prognosis of COVID-19 in Japanese ICU settings.
  • Data can inform clinical decision-making and resource allocation for severe COVID-19 cases.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
569
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
456
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
425
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
250
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
540